Mental Health

Kimberly Erlich, MSN, RN, MPH, CPNP, PMHS, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project, discusses pharmacogenomics and behavioral health in treatment of children and teens.

A new study conducted by researchers at Bar-Ilan University and the University of Haifa has linked coronavirus disease 2019 (COVID-19)-based loneliness in older adults with elevated psychiatric symptoms of anxiety, depression, and trauma symptoms that immediately follow exposure to trauma.

Dawn Lee Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, FAAN, the Immediate Past President of NAPNAP and the Associate Professor at the University of Portland in the School of Nursing, discusses caring and prescribing for children with ADHD who have other comorbidities.

Elizabeth Skoy, PharmD, and Amy Werremeyer, PharmD, BCPP, associate professors at the North Dakota State University School of Pharmacy, discuss what they feel is the value of the pharmacist.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

Mental health first aid trains participants to recognize risk factors and warning signs for mental health and addiction concerns.

Over the past 10 years, pediatric emergency department (ED) visits for mental health disorders have risen 60% and the rate of visits for deliberate self-harm have increased by 329%, according to a study published by Pediatrics.

More than one-third of Americans report that COVID-19 has had a serious impact on their mental health.

This new study showed for the first time that an enzyme, known as fatty acid synthase (FASN), specifically may be responsible for causing cognitive deficits.

Can donepezil be the cause of abnormal dreams?

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Researchers examined the long-term relationship between eating foods containing flavonoids and the risk of AD and AD-related dementias (ADRD).

The findings of a recent survey from ValuePenguin found that 55% of the 1200 respondents said their mental health is suffering because of COVID-19, more specifically in millennials (63%) and parents with younger children (64%).

Emotional, social, and psychiatric problems in children and adolescents have been linked to higher levels of genetic vulnerability for adult depression.

According to the results of a nationwide survey conducted among clinical pharmacists, too many working hours is the major factor causing burnout, followed by inadequate management.

This cohort included 307 patients with schizophrenia and 364 healthy controls who were 45 years old and younger.

With all the factors of the COVID-19 outbreak taken into consideration, simply maintaining your current body weight and level of health and fitness is a win worth celebrating.

This group of health care professionals has experienced the burdens associated with increased patient demands, the potential for exposure, and shifting role expectations.

Caplyta is an oral, once daily medicine approved for the treatment of schizophrenia in adults.

Top news from across the health care landscape.

As accessible health providers, pharmacists are well positioned to assist young people who have mental health issues.

Medication adherence is essential to avoid serious consequences, such as attempted suicide.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses how to navigate data on medications with higher risks of suicidality and depression.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, New Jersey, discusses several risk factors for patients on medications with higher risks of suicidality and depression.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, explains several tips for safely monitoring patients who are on medications with higher risks of suicidality and depression.

Almost one-third of those who suffer are treatment resistant, which can pose challenges.

PTSD can have debilitating effects, including flashbacks, nightmares, and extreme anxiety.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses the higher risk for potential adverse effects of suicidal ideation and behavior, and depression in younger patients.